Everything is interrelated on multiple levels – Andreas Plückthun designs synthetic proteins as therapeutics, for example against cancer. The current European project now supports his important high-risk basic research.
What happens if I participate in a European or international consortium? Can I still publish? Can I keep up and develop my Intellectual Property portfolio? What about confidentiality? What about limitation of liability? How do I run a project? What